Shepard DS, Thompson MS: First principles of cost-effectiveness analysis in health. Public Health Rep94: 535-543, 1979
2.
Weinstein MC , Stason WB: Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med296: 716-721, 1977
3.
Congress of the United States, Office of Technology Assessment : The implications of cost-effectiveness analysis of medical technology. Washington DC: US Government Printing Office, 1980
4.
Neuhauser D. , Lewicki AM: National health insurance and the sixth stool guaiac. Policy Anal2: 175-196, 1976
5.
McNeil BJ, Varady PD, Burrows BA, Adelstein SJ: Cost-effectiveness calculations in the diagnosis and treatment of hypertensive renovascular disease. N Engl J Med293: 216-221, 1975
6.
Patrick DL, Bush JW, Chen MM: Methods for measuring levels of well-being for a health status index . Health Serv Res8: 228-245, 1973
7.
Fanshel S., Bush JW: A health-status index and its application to health-services outcomes . Oper Res18: 1021-1066, 1970
8.
Zeckhauser R. , Shepard DS: Where now for saving lives? Law Contemp Probl40: 5-45, 1976
9.
McNeil BJ, Weichselbaum R., Pauker SG: Fallacy of the five-year survival in lung cancer. N Engl J Med299: 1397-1401, 1978
10.
Weinstein MC , Pliskin JS, Stason WB: Coronary artery bypass surgery. Decision and policy analysis. In, Bunker JP, Barnes BA, Mosteller F, eds.: Costs, risks, and benefits of surgery. New York: Oxford University Press, 1977
11.
Pliskin JS, Shepard DS, Weinstein MC: Utility functions for life years and health status. Oper Res28: 206-224, 1980
12.
Rice D.: Estimating the cost of illness. Am J Public Health57: 424-440, 1967
13.
Schoenbaum SC, McNeil BJ, Kavet J.: The swine-influenza decision. N Engl J Med295: 759-765, 1976
14.
Acton JP: Evaluating public programs to save lives. The case of heart attacks . Santa Monica, Calif.: Rand Corporation , Report R-950-RC, 1973
15.
Jones-Lee MW : The value of a life. An economic analysis . Chicago: University of Chicago Press, 1976
16.
Smith RS: Compensating wage differentials and public policy. A review. Ind Labor Relat Rev32: 338-352, 1979
17.
Rosenshein MS , Farewell VT, Price TH, Larson EB, Dale DC: The cost-effectiveness of therapeutic and prophylactic leukocyte transfusion. N Engl J Med302: 1058-1062, 1980
18.
Weinstein MC, Fineberg HV: Cost-effectiveness analysis for medical practices. Appropriate laboratory utilization. In, Benson ES, Rubin M, eds.: Logic and economics of clinical laboratory use. New York: Elsevier /North-Holland Biomedical Press, 1978
19.
Raiffa H., Schwartz WB, Weinstein MC: Evaluating health effects of societal decisions and programs. In, Decision making in the environmental protection agency, Volume 11b. Washington DC: National Academy of Sciences, 1977
Weinstein MC : Estrogen use in postmenopausal women. Costs, risks, and benefits. N Engl J Med303: 308-316, 1980
22.
Weinstein MC , Stason WB: Hypertension. A policy perspective. Cambridge, Mass.: Harvard University Press, 1976
23.
Banta HD, Thacker SB: Assessing the costs and benefits of electronic fetal monitoring. Obstet Gynecol Surv34: 627-642, 1979
24.
Commission on Professional and Hospital Activities : Length of stay in PAS hospitals, United States. Ann Arbor: Commission on Professional and Hospital Activities, published annually
25.
Fryback DG: An overview of assessment techniques for multiattribute utilities . Med Decision Making, in press
26.
Torrance GW : Social preference for health states. An empirical evaluation of three measurement techniques. Socioecon Plann Sci10: 129-136, 1976
27.
Cooper BS, Brody W.: 1972Lifetime earnings by age, sex, race, and educational level. Research and statistical note. DHEW Publication No. (SSA) 75-11701. Washington DC: U.S. Government Printing Office, 1975
28.
Bailey M.: Reducing risks to life. Measurement of the benefits. Washington DC: American Enterprise Institute, 1980
29.
Weinstein MC , Stason WB: Cost-effectiveness of coronary artery bypass surgery. Unpublished; available from the author
